- 恒指
- 25,869
- +35
- 大市成交 2,683億
- 以岭藥業
- 16.890-0.120 (-0.705%)
盈利能力分析
- 9.561
- -6.686
- 12.085
- 23.626
- 14.941
- 7.265
- -4.783
- 8.118
- 16.158
- 11.016
- 9.144
- -5.868
- 9.832
- 19.722
- 13.303
邊際利潤分析
- 60.531
- 50.187
- 57.282
- 63.771
- 63.615
- 20.235
- -10.578
- 17.249
- 22.577
- 15.510
- 19.903
- -11.942
- 16.578
- 22.346
- 15.529
- 16.986
- -11.273
- 13.028
- 18.813
- 13.261
收益指標分析
- 99.484
- 79.280
- 94.947
- 103.068
- 100.217
- -0.010
- -4.975
- 3.877
- 0.414
- -1.409
- -1.511
- 13.909
- -5.677
- -1.759
- -0.988
償債能力分析
- 1.846
- 1.663
- 1.472
- 1.496
- 1.892
- 1.285
- 0.993
- 0.919
- 1.079
- 1.327
- 24.772
- 23.403
- 32.636
- 33.111
- 29.699
- -0.284
- -0.443
- 14.733
- 16.356
- 9.743
- -33,663.951
- -21,591.475
- 554.734
- 495.085
- 889.909
- 303.857
- 327.983
- 206.624
- 202.053
- 236.627
- -643.421
- -34.699
- 64.873
- 140.593
- 90.712
營運能力分析
- 59.950
- 100.233
- 72.012
- 47.934
- 48.812
- 200.029
- 233.312
- 182.969
- 146.462
- 159.076
關稅戰
聚焦兩會2026
More